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Ethnomedicinal use of plants from the Artocarpus genus has been extensively documented to include treatment of inflammation
and malarial fever. Anti-plasmodial effects of Artocarpus scortechinii (synonym A. elasticus) reported against P. falciparum
3D7 culture in erythrocytes remain to be validated in vivo. The present study involved re-evaluation of anti-plasmodial activity
of ethanolic extract of A. scortechinii in vitro, assessment of the extract for chemo-suppressive effects in vivo, and fractionation
and identification of bioactive compounds. The ethanolic extract of A. scortechinii displayed moderate inhibitory activity
towards growth of P. falciparum 3D7 (IC50=14.4±8.1 μg/mL) with minimal toxicity effect in mammalian Chang liver cells
(selectivity index, SI=13.9). Administration of 25, 50 and 100 mg/kg body weight extract into P. berghei-infected mice for
four consecutive days resulted in dose-dependent chemo-suppression of 43.2, 74.8 and 78.4% respectively. Vacuum liquid
chromatography fractions of the ethanolic extract exhibited moderate to good in vitro anti-plasmodial activities. Further
fractionation using Sephadex Column Chromatography yielded engeletin identified by nuclear magnetic resonance spectroscopy
and mass spectroscopy. Upon further testing the isolated engeletin was shown to display an IC50 of 33.1±1.3 μM against the
3D7 parasite strain (SI=3.5). Data from the present study is the first report on anti-plasmodial activity of engeletin and its
isolation from Artocarpus scortechinii.
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INTRODUCTION
In recent years, anti-malarial research initiatives to
discover and develop new anti-malarial therapeutics
from ethnopharmacological plants resources have
increased dramatically primarily due to the
development of resistance to existing anti-malarial
agents. The Artocarpus genus of plants has received
extensive scientific attention due to the medicinally
important secondary metabolite constituents with
useful biological activities. Many of the widely-
documented investigations have been restricted to
primary screening studies using in vitro approaches.
For example, Mustapha et al. (2010) showed anti-
malarial activities in A. elasticus (also known as
A. scortechinii) employing blood smear analysis
of plasmodium-infected parasites and candle
jar method of Trager & Jensen (1975). In vivo
experiments to validate in vitro anti-plasmodial
activities of the Artocarpus plants remain scarce.
The registry of studies on anti-plasmodial effects
of Artocarpus preparations in murine models
of infection is limited to investigations by
Widyawaruyanti et al. (2007) on A. champeden.
Identification of compounds responsible for anti-
plasmodial activities in this genus of plants have
led to many bioactive compounds among
the secondary metabolite constituents. These
 include artoindonesianin Z-5, gemichalcone B,
dihydromorin, artocarpesin, cycloartocarpesin, artonin
E, 12-hidroxy artonin E, cycloartocarpin and
artobiloxanthone which have all been further
evaluated for anti-malarial activity against
chloroquine-resistant P. falciparum K1 strain
(Mustapha et al., 2010). Phytochemical charac-
terization of bioactive compounds is not only required
as a basis for development of new anti-malarial
compound(s) but is also an essential step in the
production of standardized herbal preparations.
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MATERIALS AND METHODS
Parasites and Animals
P. falciparum 3D7 (chloroquine-sensitive)
strain and P. berghei NK65 (chloroquine-sensitive)
strain were obtained from Malaria Research and
Reference Reagent Resource (MR4, USA) whereas
Chang liver cells were obtained from American Type
Culture Collection (ATCC, USA). Male ICR mice
(6-8 weeks old, 25±4 g in weight) were obtained
from the Animal House Facility at Universiti
Kebangsaan Malaysia. Permission and approval for
animal studies were obtained from the Universiti
Kebangsaan Malaysia Animal Ethics Committee
(UKMAEC-FST/2012/NOOR/21-NOV./465-DEC.-
2012-DEC.-2014).
Extraction and Fractionation of Plant Materials
Air-dried stem bark of A. scortechinii collected
from Jengka forest in the state of Pahang, Malaysia
(voucher specimen no UKMB 40193) were ground
into a powder prior to soaking in 95% ethanol for
three days at room temperature. Filtered extract was
then concentrated using a rotary evaporator (Fisher
scientific, UK) and freeze dried (Labconco, UK).
Further fractionation and separation was carried out
using vacuum liquid chromatography (VLC)
(solvent system; n-hexane: ethyl acetate, 3:7) and
Sephadex column chromatography (SCC) (solvent
system; 100% methanol). Structure of isolated
compound was identified using spectroscopic
techniques such as ultraviolet, infrared, NMR and
mass spectrometry.
In vitro Anti-plasmodial Assay
Parasite lactate dehydrogenase (pLDH) assays
(Makler & Hinrichs, 1993) were performed in flat-
bottomed 96-well plates by Nkhoma et al. (2007)
with slight modifications. Parasitized red blood cells
and un-parasitized O+ red blood cells without
treatment were used as positive and negative
controls respectively. P. falciparum 3D7 culture
was plated in the asynchronized phase at 1.5%
hematocrit and 2% parasitemia (60% rings) in
100 μL of extract or fraction from A. scortechinii
or anti-malarial drug. Extract or fraction from
A. scortechinii was serially diluted (0.01 to 1000
μg/mL) whereas reference drug, chloroquine
diphosphate (CQ) purchased from Sigma Aldrich
(USA) was diluted serially (0.02 to 20 μM). Plates
were placed in a sterile incubator (Thermo Scientific,
USA) with a gas mixture of 4% O2, 5% CO2, and
97% N2 at 37°C for 48 hours. Reagents required for
detecting and measuring the parasite LDH enzyme
were prepared as follows: Malstat reagent by
dissolving 400 μL Triton X-100 in 80 mL deionized
water, and adding 4.00 g L-lactate, 1.32 g Tris buffer
and 0.022 g 3-acetylpyridine adenine dinucleotide
(APAD+) then adjusting pH to 9.0 and final volume
topped up to 200 mL with deionized water; and
NBT/PES solution by dissolving 0.160 g
nitrotetrazolium blue salt (NBT) together with 0.008
g phenazine ethosulfate (PES) in 100 mL deionized
water and stored at 4oC in a foil-covered container.
Upon completion of incubation, cultures were
subjected to three 30-minute freeze–thaw cycles.
This was followed by the addition of 100 μL Malstat
reagent and 25 μL NBT/PES to each well of a fresh
second set of flat-bottomed 96-well plate in
triplicates. The culture in each well from the first
set of plates was re-suspended and 15 μL cultures
were added to the second set of 96-well plates to
initiate the lactate dehydrogenase enzymatic
reaction. Color development of the pLDH plate was
then monitored colorimetically at 650 nm (Fluorostar
OPTIMA) after one hour of incubation in the dark.
Data obtained was analyzed for IC50 values
(inhibition concentration at 50% parasite growth)
by Graph Prism 5 software through non-linear
regression.
In Vitro Cytotoxicity Assay
Cytotoxicity of extracts was determined using
3-(4, 5-dimethylthiazol-2-yl)-2, 5 diphyenylte-
trazolium bromide (MTT) assay (Mossmann, 1983).
On the day of test, Chang liver cells were harvested,
counted and cell number adjusted to 2 ×104 cells per
mL. Then, 100 μL cell suspensions in complete
Dulbecco’s Modified Eagle Medium (DMEM) were
seeded into each well of a 96-well plate. At the end
of 24 hours of culture, medium was removed, and
100 μL of diluted extracts added in triplicates. The
final concentration of the extracts in test wells
ranged from 0.01 to 10 mg/mL. Cell suspension
without test substance (100 μL) was used as positive
control. The culture was incubated in the presence
or absence of extract for 48 hours, 37ºC, 5% CO2
(Thermo Scientific, USA). MTT reagent was prepared
in phosphate buffered saline (PBS) at 5 mg/mL.
Then, 10 μL of MTT-PBS reagent was added to each
well containing 100 μL complete DMEM. The plates
were further incubated for 3 hours (37ºC, 5% CO2).
The medium was then removed and replaced with
100 μL of dimethyl sulphoxide (DMSO) to dissolve
the MTT formazan product. The mixture was
thoroughly mixed for 15 minutes before measuring
the absorbance at 540 nm (Fluorostar OPTIMA). The
growth curve and the concentration at 50% growth
inhibition (IC50) were estimated through non-linear
regression software Graph Prism 5.
In vivo Anti-malarial Activity Evaluation
Anti-malarial activity evaluation of extract was
carried out based on the four-day suppressive test
described by Peters (1975). Inoculum used consisted
of 5×106 P. berghei-parasitized erythrocytes/mL,
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determined based on the percentage of parasitaemia
and the erythrocyte count in stock mouse and blood
dilution with Alsever’s buffer. Extracts were diluted
with 0.9% saline solution with 10% dimethyl
sufoxide (DMSO) to yield 25, 50 and 100 mg/kg
body weight (bw) final concentration in 0.2 mL
injection volume. CQ was freshly prepared at 10
mg/kg bw in 0.9% normal saline. A total of 42 mice
were randomly divided into six groups of seven mice
each. P. berghei NK65 infection was done to all
groups of mice on day 0 (D0). After three hours of
infection, treatment groups were intraperitoneally
administered with the first dose of 0.2 mL extract.
Administration of extract was repeated for three
additional days (D1, D2 and D3). Two groups (n=7)
served as negative and positive controls; the
negative control group received a placebo (0.9%
saline solution) while the positive controls received
10 mg/kg bw CQ. Dose of 10 mg/kg bw CQ was
chosen because of the reported 100% parasite
clearance (Peters 1975) associated with this dose in
in vivo four-day suppressive tests. In addition, 10
mg/kg bw CQ did not cause death in P. berghei-
infected mice (Peters 1975). Thin and thick blood
smears from mice tail were prepared beginning D1
until D20 to measure parasitaemia levels and
observe morphology of infected erythrocytes.
Average chemo-suppressive activities were
calculated according to Gathirwa et al. (2007):
Chemo-suppression (%) = [(A - B)/A] x 100
where A is the mean parasitaemia for negative
control group on day 4 (D4) and B is the
corresponding parasitaemia for treatment or positive
control group.
In vivo Toxicity Evaluation
This investigation was aimed at evaluating the
extract for toxicity effects at the dosages used in the
in vivo experiments. Male, white, ICR strain, 6-8
weeks old mice were randomly grouped into seven
mice in each group. Five groups were administered
with 0.2 mL of each 25, 50, 100 and 250 mg/kg bw
respectively. One positive control group was given
0.9% saline. Extract administration was given to
mice (i.p.) for four consecutive days (D0-D3). Death
of mice was monitored for two weeks and data
analyzed using Kaplen-Meier analysis (Bewick et
al., 2004). Gross changes in behaviour, like gasping,
low activity, vomiting and death were also observed
and recorded.
Statistical Analysis
Data obtained from in vitro and in vivo activities
were analyzed statistically using Student’s t-test and
Kaplen-Meier analysis. Treatments given were
considered significant if p<0.05.
RESULTS
Extraction and Fractionation
A. scortechinii plant materials (0.36 kg) which
were air-dried at room temperature and extracted using
ethanol yielded 19.8 g extract. Ethanolic extract of
A. scortechinii was further fractionated using vacuum
liquid chromatography (VLC) to yield five fractions;
fraction A (303.3 mg), fraction B (22.3 mg), fraction
C (129.1 mg), fraction D (100.1 mg) and fraction E
(771.7 mg). Fraction C was further purified through
Sephadex column chromatography (SCC) to afford
pale yellow crystals.
Identification of Compounds
The pale yellow crystals obtained from A.
scortechinii were subjected to spectroscopic
analysis: ESI-MS (positive mode); m/z 457.1102
[M+Na]+ calculated for C21H22O10, 434; (UV) λmax
nm; 215, 291 and 320 nm and infrared (IR); 1644,
1432, 1736, 3445, 1227 and 1092 cm-1 suggested
the isolated compound is a flavonoid (Mabry et al.,
1970). The 1H and 13C NMR of data (Table 1) is
in accordance to a flavanone glycoside and
characterized as 5,7,4’-trihydroxyflavanone-3-O-α-
L-rhamnopyranoside or engeletin previously
isolated and identified by Xu et al. (2005) from
roots of Smilax brockii. Interestingly, identification
of engeletin from stem bark of A. scortechinii has
not been reported.
Table 1. 1H and 13C-NMR data for engeletin isolated from
A. scortechinii (600MHz and 150 MHz respectively,
CD3COCD3)
Chemical shift, δH, ppm Chemical
No. (double spin, constant shift,
coupling, Hz) δC, ppm
2 5.24 (d, 10.8) 82.4
3 4.71 (d, 10.8) 76.6
4 – 195.3
5 – 164.4
5-OH 11.92 (s) –
6 5.95 (d, 1.8) 96.3
7 – 166.8




2’ 7.43 (d, 8.4) 129.1
3’ 6.90 (d, 8.4) 115.3
4’ – 158.2
5’ 6.90 (d, 8.4) 115.3
6’ 7.43 (d, 8.4) 129.1
1’’ 4.04 (d, 1.2) 101.6
2’’ 3.53 (m) 70.5
3’’ 3.64 (ddd, 9.6, 6.0, 3.6 Hz) 71.3
4’’ 3.30 (ddd, 13.6, 11.4, 3.6 Hz) 72.6
5’’ 4.21 (m) 69.0
6’’ 1.13 (d, 6.0 Hz) 17.1
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Table 2. In Vitro Anti-plasmodial and Cytotoxic Activities of Extract/Fractions and Isolated Compounds from
A. scortechinii
Sample from Cytotoxicity Activity Anti-plasmodial Activity Selectivity Index (SI)
A. scortechinini against Chang liver cell, against P. falciparum 3D7,    IC50 MTTIC50 ± SD (µg/mL) IC50 ± SD (µg/mL) =  IC50 pLDH
Ethanolic extract >500 14.4 ± 8.1 34.7
Fraction A 122.4 ± 1.3 3.7 ± 1.3 33.2
Fraction B 30.5 ± 1.7 47.0 ± 1.4 0.7
Fraction C 155.2 ± 2.3 1.8 ± 0.1 85.7
Fraction D 186.6 ± 1.4 47.1 ± 1.3 4.0
Fraction E 290.8 ± 1.6 57.9 ± 0.1 5.0
Engeletin 116.0 ± 0.2 µM 33.1 ± 1.3 µM 3.5
Choroquine ND 58.1 nM ND
Susceptibility of 3D7 strain of P. falciparum to A. scortechinii extracts and fractions were evaluated. SI (index of selectivity
towards parasite relative to mammalian cell) = IC50 MTT/IC50 pLDH. Experiments were carried out in triplicates and repeated at
least twice. CQ was used as reference anti-malarial drug. (SD; standard deviation, ND; not determined)
In Vitro Anti-plasmodial and Cytotoxic Assays
Evaluations of pLDH in P. falciparum 3D7
cultures incubated with varying concentrations of
ethanolic extract, fractions and pure compound from
A. scortechinii yielded typical sigmoid dose
response curves. Inhibition(s) of P. falciparum 3D7
growth was moderate for ethanolic extract of A.
scortechinii (IC50=14.4±8.1 μg/mL) (Table 2).
Minimal toxicity effects were observed with extract
toward Chang liver cells (IC50= >500 μg/mL) thus
the extract displayed high selectivity index (SI)
towards the parasite of 34.7. Fractions A, B, C, D
and E displayed moderate to active anti-plasmodial
activities in vitro against 3D7 (IC50= 3.7±1.3,
47±1.4, 1.8±0.1, 47.1±1.3 and 57.9±0.1 μg/mL
respectively) and minimal effects on Chang liver
cells with SI values ranging from 0.6 to 33.3 (Table
2). Engeletin isolated from fraction C exhibited
moderate anti-plasmodial activity and low inhibition
of Chang liver cell growth (IC50=33.1±1.3 μM and
116.0±0.2 μM respectively and SI=3.5). The
reference drug CQ displayed an IC50 of 58.1 nM
(0.03 μg/mL).
In vivo Anti-malarial Test
Administration of 25 to 100 mg/kg bw of
ethanolic extract of A. scortechinii for four
consecutive days did not cause any deaths in mice
(Table 3). However, at a dosage of 250 mg/kg bw,
one death occurred on day 7 implicating mild
toxicity effect. Three selected dosages of 25, 50 and
100 mg/kg bw administered for four consecutive
days into P. berghei NK65-infected ICR mice caused
significant inhibition of parasite development. Good
Fig. 1. Structure of Engeletin from Stem Bark of A. scortechinii
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chemo-suppressive activity exceeding 70% was
achieved for both 50 and 100 mg/kg bw dosages
tested (Table 3).
The observed dose-dependent chemo-
suppressive activities for ethanolic extract of
A. scortechinii is summarized together with
experimental animal survival data in Table 3. P.
berghei-infected mice administered with extracts
survived beyond the survival period for non-treated
mice. Noteworthy is the 100% survival in mice
injected with 50 and 100 mg/kg bw extract 20 days
after start of experiment as observed in animals
administered the reference drug, chloroquine
diphosphate (CQ). Infected mice treated with CQ
(10 mg/kg bw) was completely free from parasite
on day 4 onwards (Table 3) (99.9% of chemo-
suppression). However, at the lowest dosage of 25
mg/kg bw extract tested, low (43%) chemo-
suppressive activity was obtained. This dose was not
able to prolong mice survival compared to non-
treated animals.
Table 3. In vivo parasitaemia level, chemo-suppressive activity and survival of ethanolic extract of A. scortechinii on
day 4 (D4)
Extract/Drug Dosage Average Parasitaemia Suppression of Median of Mice(mg/kg bw/day) at D4 ± SD Parasitemia at D4 (%) Survival (Day)
Ethanolic extract of A. scortechinii 25 1.9 ± 0.9 43.2 14
50 0.9 ± 0.5* 74.8* 24
100 0.7 ± 0.7* 78.4* 25
Chloroquine 0.9% Saline Solution 10 0.1 ± 0.1* 99.9* >30
0.2 mL 3.3 ± 1.1* – 18
Inoculation of P. berghei NK65 was carried out in all groups of animals three hours prior to administration. Mice (n=7 per group) were treated
with extract at different dosages (25, 50 and 100 mg/kg bw) for four consecutive days (D0 to D3). CQ (10 mg/kg bw) and 0.2 mL saline
solution were used as positive and negative controls respectively. (SD; standard deviation, *shows significant value, p<0.05).
Fig. 2. Percentage of inhibition of P. berghei growth
Percentages of inhibition of parasite growth in vivo and standard deviations at day 4 post-infection
in all groups of mice infected with P. berghei NK65 intraperitoneally and treated with indicated
doses of ethanolic extract of A. scortechinii compared with non-treated controls. Day 0 corresponds
to the day of P. berghei infection.
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DISCUSSION
Here we re-evaluated crude ethanolic extract of
A. scortechinii (synonym A. elasticus) for anti-
plasmodial activity in vitro and showed similar
moderate inhibition against chloroquine-sensitive
P. falciparum 3D7 as previously reported by
Mustapha et al. (2010). Consequent in vivo
assessment of the ethanolic extract provided for the
first time direct evidence that A. scortechinii was
capable of suppressing chloroquine-sensitive P.
berghei NK65 parasitaemia development in a murine
model of malarial infection. As an extension to the
investigation using crude extract from A.
scortechinii, our study revealed that all fractions
prepared from ethanolic extract displayed moderate
to good anti-plasmodial activities implicating the
presence of potential anti-plasmodial lead
compounds in the fractions (Rasoanaiva et al.,
2004). Of these fractions, fraction C was selected for
purification and isolation of bioactive compounds
based on strong inhibitory activity toward parasite
and more efficient chromatographic separation. A
previous report on anti-plasmodial activity of A.
elasticus attributed parasite inhibition to several
isolated compounds; artoindonesianin Z-5,
gemichalcone B, dihydromorin, artocarpesin,
cycloartocarpesin, artonin E, 12-hidroxyartonin E,
cycloartocarpin and artobiloxanthone (Mustapha
et al., 2010). Our study here revealed the presence
of engeletin identified via spectroscopic analysis in
fraction C derived from A. scortechinii ethanolic
extract. Engeletin or 5,7,4’-trihydroxyflavanone-3-
O-α-L-rhamnopyranoside is a flavonoid compound
isolated from many plants of importance in
traditional medicine (McIntyre et al. 1989; Huang
et al., 2011; Wungsintaweekul et al., 2011; Chen
et al., 2011; Ruangnoo et al., 2012;) with reported
bioactivities including anti-inflammatory properties
(Huang et al., 2011; Ruangnoo et al., 2012), anti-
oxidant and anti-HIV-1 integrase activities (Itharat
et al., 2012), estrogenic and anti-estrogenic effects
(Wungsintaweekul et al., 2011), a role in the
prevention of immunological hepatocyte damage
and anti-hyperuricemic and nephroprotective effects
(Chen et al., 2011). However, anti-malarial activity
of engeletin has not been documented before. The
relatively low selectivity indices (SI<10) for
engeletin and the ethanolic extract the compound
was derived from, was contrary to that earlier
reported for the extract by Tanamatayarat et al.
(2000). It is however interesting to note that fraction
C itself exhibited better selectivity than engeletin
or the crude extract implicating presence of other
potential anti-malarial compounds in the fraction.
A. scortechinii and plants from the Artocarpus sp.
are rich in flavonoids, terpenoids, stilbenoids and
arylbenzofurons (Hakim et al., 2006) contributing
toward a myriad of pharmacological effects, such
as anti-bacterial (Khan et al., 2003), anti-platelet
(Weng et al., 2006), anti-fungal (Jayasinghe et al.,
2004) and cytotoxic (Ko et al., 2005 & Shah et
Fig. 3. Survival of mice after infection with P. berghei NK65 and administered with ethanolic extract of A. scortechinii
intraperitoneally at different dosages (25, 50 and 100 mg/kg bw). Chloroquine diphosphate (CQ) (10 mg/kg bw) and 0.9%
saline solution (0.2 mL) were used as positive control and negative control respectively.
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al., 2006) actions. Artocarpus sp. compounds
already identified with anti-plasmodial activity
include artocapones A and B, artonin A,
cycloheterophyllin, artoindonesianin E,
artoindonesianin R, heterophyllin, heteroflavanone C
and artoindonesianin A-2 (Jagtap & Bapat, 2010).
Therefore in addition to engeletin isolated in this study
from A. scortechinii, other bioactive lead compounds
remain to be identified in active fractions.
CONCLUSION
In essence, our findings provide in vivo evidence for
the anti-malarial potential of Artocarpus genus in
general and A. scortechinii in particular. Further
isolation will be carried out to explore more
potential anti-malarial leads.
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